Skip to content
drillr.ai
Sign up

BNTC

Benitec Biopharma Inc.

NASDAQ · Healthcare · Biotechnology · US

$12.68
+1.93%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue556.0K——75.0K73.0K
Cost of Revenue635.0K396.0K343.0K—9.0K
Gross Profit(79.0K)(396.0K)(343.0K)75.0K64.0K
Operating Expenses
R&D Expense19.2M18.3M15.6M12.8M11.3M
SG&A Expense34.7M23.4M7.0M6.4M6.6M
General & Admin Expense34.7M23.4M7.0M6.4M6.6M
Selling & Marketing Expense—————
Other Expenses(119.0K)—(108.0K)——
Total Operating Expenses53.8M41.8M22.5M19.2M17.9M
Cost and Expenses53.9M41.8M22.5M19.2M17.9M
Operating Income (EBIT)(53.9M)(41.8M)(22.5M)(19.1M)(17.9M)
Non-Operating
Interest Income1.6M—904.0K——
Interest Expense(3.4M)(3.3M)—33.0K32.0K
Net Interest Income5.0M3.3M904.0K(33.0K)(32.0K)
Other Non-Op Income/Expense5.1M3.8M739.0K(481.0K)(354.0K)
Non-Operating Income (excl Interest)————322.0K
EBT (Pre-Tax Income)(48.9M)(37.9M)(21.8M)(19.6M)(18.2M)
Income Tax Expense—————
Bottom Line
Net Income(48.9M)(37.9M)(21.8M)(19.6M)(18.2M)
Earnings from Cont. Ops(48.9M)(37.9M)(21.8M)(19.6M)(18.2M)
Earnings from Discont. Ops—————
Bottom Line Net Income(48.9M)(37.9M)(22.4M)(19.6M)(18.2M)
Per Share
Basic EPS($1.11)($1.05)($2.68)($14.12)($19.31)
Diluted EPS($1.11)($1.05)($2.68)($14.12)($19.31)
Revenue Per Share$0.01$0.00$0.00$0.05$0.04
Shares
Basic Shares Outstanding49.4M36.2M10.3M1.4M1.9M
Diluted Shares Outstanding49.4M36.2M10.3M1.4M1.9M
Profitability Metrics
EBITDA(53.5M)(41.4M)(22.1M)(18.7M)(17.8M)
D&A475.0K396.0K343.0K381.0K392.0K
EBIT(53.9M)(41.8M)(22.5M)(19.1M)(18.2M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026